News & Events

Althea releases new investor presentation detailing European expansion and strategic growth plan

Investment Highlights:

  • ASX-listed global cannabis company with rapidly expanding operations in Europe, NorthAmerica, Australia and Africa
  • Vertically integrated with capabilities spanning the manufacturing, sales and distribution of pharmaceutical and non-pharmaceutical cannabis-based products
  • Strong financial performance, news flow, and cash position
  • Massive market opportunity – undervalued against peer group

For full ASX announcement – read here

Healthcare Professional Resource Centre

Continue